TerminatedNCT00907985

A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects

Medication studyAges 18–65GermanyBipolarity

The study in practice

Understand this study

This study is for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: May 15, 2009

Recruitment status: Terminated
Enrollment listed in the registry: 12
Sponsor: GlaxoSmithKline
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 1
Locations: Germany
Age range: From 18 Years to 65 Years
Official registry ID: NCT00907985
Official title: Show the full official title
Double Blind, Double-dummy, Randomised, Placebo Controlled Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects

Terminated

Göttingen

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is GlaxoSmithKline.

Does this study involve medication?

Yes. The study involves medication, including Placebo, Vofopitant and lamotrigine.

Who can participate?

This study is for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.